Last reviewed · How we verify

NCT06375291

Pregnancy-Related Carpal Tunnel Syndrome Treatment

Completed Last updated 22 April 2024
What this trial tests

trial testing splint /steroid injection/both in Carpal Tunnel Syndrome Pregnancy in 45 participants. Completed in 31 March 2024.

Timeline
1 January 2021
Primary endpoint
31 December 2023
31 March 2024

Quick facts

Lead sponsorMersin Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment45
Start date1 January 2021
Primary completion31 December 2023
Estimated completion31 March 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mersin Training and Research Hospital

Who can join

Adults 18 to 35, female only, with Carpal Tunnel Syndrome Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current retrospective study aimed to compare the effectiveness of local steroid injection plus splinting with that of local steroid injection or splinting alone. To assess the primary outcome, The Boston Carpal Tunnel Symptom Severity Scale was used. The secondary aim was the efficacy of the treatment on the patient's function severity and depression assessed by The Boston Carpal Tunnel Symptom Function Scale Edinburgh Depression Scale.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mersin Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06375291.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing